The CANNADORF Advantage
GROWING STERILE CANNABIS TISSUE CULTURE IN BIOREACTORS
Our bioreactors allow for precise manufacturing under cGMP conditions. It is the only true and homogeneous manufacturing system for sterile pharma-grade Cannabis API and is directed toward pharmaceutical usage. With CANNADORF’s bioreactors, fast growth, consistent and reproducible
high crop yield, without loss, is enjoyed.
For intended cannabinoids and terpene content, based on known metabolic regulation genes expression from model plants, NGS and bioinformatics. This allows for the manipulation of expression of regulation genes of specific enzymes, and allows us to control the cannabinoids profile as well as increase and reduce specific metabolites for high and specific API yield.
IN VITRO MICROPROPAGATION
Our innovative in-vitro micropropagation technology allows for healthy plants free from pests and diseases, significantly reduced growing space, low maintenance care, mass production, saved genetics (exact copies from the parent plant), and economic savings on space, energy, and additional expenditures.
CANNADORF’s breeding technology can reduce breeding cycles by up to five years, saving precious time and business expenses.
The Cannabis Tissue Culture Bioreactor
Through our unique technology, we offer pharmaceutical-grade manufacturing technology for cannabinoids to the cannabis industry. We are currently developing a cGMP bioreactor to manufacture sterile cannabis using cannabis tissue culture.
Our technology is based on many years of academic research and development with collaboration from top researchers at The Hebrew University of Jerusalem.
Benefits of Our Technology:
The only true and homogeneous manufacturing system for pharma-grade cannabis API, aimed toward pharmaceutical drug use
Trichome production by sterile tissue culture
Manufacturing under cGMP conditions
Fully sterile processes
We implement a precise process
Usage of a controlled environment
Fast growth with a consistent and reproducible high crop yield, all without yield loss
We facilitate biological in vivo manufacturing of essential cannabinoids and terpenes, based on known metabolic regulation gene expressions.
- For intended cannabinoids and terpene content, based on known metabolic regulation genes expression from model plants, NGS and bioinformatics
- Expression of known early flowering genes in cannabis plants to generate small plants with multiple flowering for indoor growth and short life cycle
- Changing the architecture of the flowers to ensure disease-free cannabis plants without yield loss
- Metabolic engineering
- Controlling the cannabinoids profile
In Vitro Micropropagation
- Produces healthy plants through sterile processes with no pests and diseases, and the ability to remove viruses if needed
- Significantly reduced growing space
- This type of growth requires less routine attention making it quite low maintenance
- Plants can be stored in a limited vegetative stage for longer periods
- The number of plants can be multiplied exponentially allowing for massive production
- With saved genetics, you gain exact copies from the mother plant
- Benefit from reduced business expenses by saving space, energy, and more
Our bioreactors are the only true and homogeneous manufacturing system for pharma grade Cannabis API, aimed toward pharmaceutical drug use. Benefit from precise manufacturing under cGMP conditions, trichome production by sterile tissue culture, and fast growth, consistent and reproducible high crop yield– all without yield loss.
Why does it matter? With our bioreactors we are able to control gene expression and the synthesis of specific cannabinoids by genome editing in cannabis plants. Expression regulation of specific enzymes allows CANNADORF to control the cannabinoids’ profiles. This, in turn, provides the ability to increase and decrease specific metabolites for high and specific API yield.
Through CANNADORF’s micropropagation laboratory we ensure the production of healthy plants free from pests and diseases through a sterile process. With significantly reduced growing space, low maintenance care, and plants that can be stored in a limited vegetative state for longer periods of time, invaluable business expenses and logistics can be spared.
CANNADORF offers a full range of cannabinoids profile of medical cannabis, according to the Israeli IMC-GAP table. All of our strains are pathogen and disease free (virus pathogens and pests) due to sterile tissue culture reproduction process. CANNADORF will offer a library of medical cannabis strains with a consistency of cannabinoids , terpenes and flavonoids based on our unique tissue culture technology.
Our innovative tissue culture technology gives us the opportunity to supply our future customers medical cannabis plants with 100% consistency in cannabinoids, terpenes and flavonoids. Additionally, we also offer a full range of cleaning services for medical cannabis lines, and a reserve unit for plant material services.
HERBS EXTRACTION DEVICE
We offer a fully automated small device solution for herbs oil extraction. Our solution is safe for users and the environment and prepares Herbs extraction from a minimum of 5 grams. It boasts an attractive price (400 USD) and is about the size of a coffee maker. It’s perfect for homemade special formulations from Cannabis and other plants.
At CANNADORF we’re enhancing nature and leading new innovations within the cannabis industry. Please check back for career opportunities.
Fantasy networks Ltd, (FMST), a public company traded at the Tel Aviv Stock Exchange.
Interested in investment opportunities? Let’s talk!